Researchers uncover anti-CRISPR proteins that could help genetic engineering to be safer.
In PNAS this week: deep phenotyping of xeroderma pigmentosum, role of PREX2 mutations in melanoma development, and more.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
The recent funding round follows $25 million that the company raised in January 2010.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
The drug maker Daiichi Sankyo will use Gene Bridges' DNA recombination technology.
University of Illinois at Urbana-Champgain, 23andMe, Michael J. Fox Foundaton for Parkinson's Research, Parkinson's Institute and Clinical Center, SeqWright, Roche NimbleGen, Chronix Biomedical, Genome Atlantic, Agilent Technologies
Cloning in the kitchen? Sandra Porter checks out the DIYbio group and finds some great principles and some not-so-great biology.
In a talk at the AAAS meeting in Chicago, Stanford University bioengineer Drew Endy said that the US needs a national initiative to support and encourage synthetic biology.
In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.
Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.
HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.
Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.